Overview
Umashanker Navik practices practicing medicine in Bathinda, India.
Navik is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Rhabdomyosarcoma, Non-Alcoholic Fatty Liver Disease, and Cirrhosis.
They are actively involved in clinical research, co-authoring 60 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Umashanker Navik
Is Umashanker Navik a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?
MediFind is an objective health platform that identifies experts based on real-world data. Umashanker Navik is classified as an Advanced expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Umashanker Navik participate in research or clinical trials?
Yes. Umashanker Navik has published 60 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Umashanker Navik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nonalcoholic Steatohepatitis (NASH)
- Experienced
- ArthritisNavik isExperienced. Learn about Arthritis.
- Cardiomyopathy Due to Anthracyclines
- CirrhosisNavik isExperienced. Learn about Cirrhosis.
- COVID-19Navik isExperienced. Learn about COVID-19.
- Doxorubicin-Induced Cardiomyopathy
- Maturity Onset Diabetes of the Young
- Non-Alcoholic Fatty Liver Disease
- RhabdomyosarcomaNavik isExperienced. Learn about Rhabdomyosarcoma.
- Type 2 Diabetes (T2D)Navik isExperienced. Learn about Type 2 Diabetes (T2D).